author-photo

David E Gilham

11

Papers

245

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (106)
Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy

2018 Cytotherapy
Show All
- Source
- Cite
- Save
Citations (32)
37PPooling signaling and costimulatory domains in a flexible CARpool design

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Iconographies supplémentaires de l'article : Celyad's novel CAR T-cell therapy for solid malignancies

2018
Show All
- Source
- Cite
- Save
Citations (0)
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

2018 Haematologica
Show All
- Source
- Cite
- Save
Citations (37)
Exploiting natural killer group 2D receptors for CAR T-cell therapy

2017 Future Oncology
Show All
- Source
- Cite
- Save
Citations (27)
A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1203PFunctional screening of B7H6-based chimeric antigen receptor (CAR) designs

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)